Literature DB >> 11415515

Multiple interacting gene products may influence susceptibility to malignant hyperthermia.

R L Robinson1, J L Curran, F R Ellis, P J Halsall, W J Hall, P M Hopkins, D E Iles, S P West, M A Shaw.   

Abstract

Malignant hyperthermia (MH) is a potentially lethal disorder triggered in susceptible individuals on exposure to common anaesthetic agents. Crises reflect the consequences of disturbed skeletal muscle calcium homeostasis. MH is an autosomal dominant, genetically heterogeneous trait. Defects in a single major gene have been assumed to determine susceptibility status in individual families. However, in some pedigrees phenotypic and genotypic data are discordant. One explanation, in contrast to the current genetic model, is that susceptibility is dependent upon the effects of more than one gene. Using the transmission disequilibrium test we assessed the involvement of 8 MH candidate loci (RYR1, CACNA1S, CACNA2D1, MHS4 at 3q13.1, MHS6 at 5p, LIPE, DM1, dystrophin) by analysis of data from 130 MH nuclear families. Results suggested that variations in more than one gene may influence MH susceptibility in single families.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11415515     DOI: 10.1017/S0003480000008186

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  15 in total

1.  Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants.

Authors:  Senthilkumar Sadhasivam; Barbara W Brandom; Richard A Henker; John J McAuliffe
Journal:  Pharmacogenomics       Date:  2019-09       Impact factor: 2.533

2.  Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1.

Authors:  J R Lopez; V Kaura; C P Diggle; P M Hopkins; P D Allen
Journal:  Br J Anaesth       Date:  2018-08-10       Impact factor: 9.166

3.  Novel SNPs of the bovine CACNA2D1 gene and their association with carcass and meat quality traits.

Authors:  Zheng Rong Yuan; Shang Zhong Xu
Journal:  Mol Biol Rep       Date:  2010-06-29       Impact factor: 2.316

Review 4.  Neurological channelopathies.

Authors:  T D Graves; M G Hanna
Journal:  Postgrad Med J       Date:  2005-01       Impact factor: 2.401

Review 5.  Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept.

Authors:  Sheila Riazi; Natalia Kraeva; Philip M Hopkins
Journal:  Anesthesiology       Date:  2018-01       Impact factor: 7.892

6.  Eccentric contractions do not induce rhabdomyolysis in malignant hyperthermia susceptible mice.

Authors:  Benjamin T Corona; Clement Rouviere; Susan L Hamilton; Christopher P Ingalls
Journal:  J Appl Physiol (1985)       Date:  2008-09-11

7.  Screening for mutations in the RYR1 gene in families with malignant hyperthermia.

Authors:  Viviane P Muniz; Helga C A Silva; Ana Maria C Tsanaclis; Mariz Vainzof
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

8.  Assessing the pathogenicity of RYR1 variants in malignant hyperthermia.

Authors:  A Merritt; P Booms; M-A Shaw; D M Miller; C Daly; J G Bilmen; K M Stowell; P D Allen; D S Steele; P M Hopkins
Journal:  Br J Anaesth       Date:  2017-04-01       Impact factor: 9.166

9.  A double mutation of the ryanodine receptor type 1 gene in a malignant hyperthermia family with multiminicore myopathy.

Authors:  Seul-Ki Jeong; Dong-Chan Kim; Yong-Gon Cho; Il-Nam Sunwoo; Dal-Sik Kim
Journal:  J Clin Neurol       Date:  2008-09-30       Impact factor: 3.077

10.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.